Author Hohloch, Karin

• 1999 | Journal Article
  ​ ​Rapid mucosal CD4+ T-cell depletion and enteropathy in simian immunodeficiency virus–infected rhesus macaques​
  Kewenig, S.; Schneider, T.; Hohloch, K.; Lampe–Dreyer, K.; Ullrich, R.; Stolte, N. & Stahl–Hennig, C. et al.​ (1999) 
  Gastroenterology, 116(5) pp. 1115​-1123​.​ DOI: https://doi.org/10.1016/S0016-5085(99)70014-4 
  ​Details  DOI 

• 2003 | Journal Article
  ​ ​Aplastic anemia - Diagnosis​
  Hohloch, K.; Truemper, L. H. & Schroers, R.​ (2003) 
  DMW - Deutsche Medizinische Wochenschrift, 128(36) pp. 1838​-1840​.​
  ​Details  PMID  PMC  WoS 

• 2003 | Journal Article
  ​ ​Aplastic anemia - Treatment​
  Schroers, R.; Hohloch, K. & Truemper, L. H.​ (2003) 
  DMW - Deutsche Medizinische Wochenschrift, 128(36) pp. 1841​-1844​.​
  ​Details  PMID  PMC  WoS 

• 2003 | Journal Article | 
  ​ ​Aplastic anemia - Case Report​
  Schroers, R.; Hohloch, K. & Truemper, L. H.​ (2003) 
  Deutsche medizinische Wochenschrift, 128(36) pp. 1837​-1837​.​ DOI: https://doi.org/10.1055/s-2003-41962 
  ​Details  DOI  PMID  PMC  WoS 

• 2004 | Conference Paper
  ​ ​Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group​
  Kollmannsberger, C.; Beyer, J.; Liersch, R.; Schoeffski, P.; Metzner, B.; Rick, O. & Hartmann, J. T. et al.​ (2004)
  Journal of Clinical Oncology, 22(1) pp. 108​-114. ​39th Annual Meeting of the American-Society-of-Clinical-Oncology​, CHICAGO, ILLINOIS.
  Alexandria​: Amer Soc Clinical Oncology. DOI: https://doi.org/10.1200/JCO.2004.06.068 
  ​Details  DOI  PMID  PMC  WoS 

• 2005 | Conference Abstract
  ​ ​Tandem high dose chemotherapy and myeloablative radioimmunotherapy with 131-I-anti-CD20 rituximab in relapsed and refractory B-cell lymphoma: Interim results of a phase II study of the German RIT study group​
  Hohloch, K.; Wulf, G.; Glass, B.; Jung, W.; Stitz, E.; Meller, J. & Sahlmann, C.-O. et al.​ (2005)
  Annals of Oncology, 16 ​9th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

• 2005 | Conference Abstract
  ​ ​Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics of melphalan​
  Kuhne, A.; Kaiser, R.; Schirmer, M. A.; Muhlke, S.; Niere, W.; Wasser, K. & Overbeck, T. R. et al.​ (2005)
  European Journal of Clinical Pharmacology, 61(9) ​7th Annual Congress of Clinical Pharmacology​, Dresen, GERMANY.
  New york​: Springer.
  ​Details  WoS 

• 2005 | Conference Abstract
  ​ ​Pharmacokinetics of melphalan and genotypes of glutathione S-transferases GSTM1 and GSTT1 and correlation to adverse effects.​
  Kuhne, A.; Muhlke, S.; Heider, U.; Overbeck, T. R.; Hohloch, K.; Meineke, I. & Truemper, L. H. et al.​ (2005)
  Journal of Clinical Oncology, 23(16) ​41st Annual Meeting of the American-Society-of-Clinical-Oncology​, Orlando, FL.
  Alexandria​: Amer Soc Clinical Oncology.
  ​Details  WoS 

• 2006 | Conference Abstract
  ​ ​CHOP/CHOEP-14 followed by consolidation with alemtuzumab in untreated aggressive T-cell lymphomas (DSHNHL 2003-1): Feasibility and toxicity of a phase II trial of the German High Grade Non-Hodgkin's Lymphoma Group DSHNHL.​
  Truemper, L. H.; Hohloch, K.; Kloess, M.; Duehrsen, U.; Eimermacher, H.; Haas, A. & Aldaoud, A. et al.​ (2006)
  Journal of Clinical Oncology, 24(18) ​42nd Annual Meeting of the American-Society-of-Clinical-Oncology​, Atlanta, GA.
  Alexandria​: Amer Soc Clinical Oncology.
  ​Details  WoS 

• 2007 | Journal Article
  ​ ​Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan​
  Kühne, A.; Kaiser, R.; Schirmer, M.; Heider, U.; Muhlke, S.; Niere, W. & Overbeck, T. et al.​ (2007) 
  Pharmacogenetics and Genomics, 17(7) pp. 505​-517​.​ DOI: https://doi.org/10.1097/FPC.0b013e3280ea77cd 
  ​Details  DOI  PMID  PMC  WoS 

• 2008 | Conference Abstract
  ​ ​Significant dose escalation of Idarubicin in the treatment of low risk aggressive non-Hodgkin's lymphoma leads to increased hematotoxicity and decreased efficacy: Nine year follow up of a phase-I/II trial of the DSHNHL​
  Hohloch, K.; Zwick, C.; Zeipert, M.; Kaiser, U.; Engert, A.; Reiser, M. & Hoeffkes, H.-G. et al.​ (2008)
  Annals of Oncology, 19 ​10th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

• 2008 | Conference Abstract
  ​ ​Tandem HD-chemotherapy and myeloablative radioimmunotherapy with 131I-anti-CD20 rituximab in relapsed and refractory B-cell lymphoma: Final results of a phase II study of the German Rait Study Group​
  Hohloch, K.; Lakhani, V. J.; Sahlmann, C.-O.; Wulf, G.; Jung, W.; Glass, B. & Meller, J. et al.​ (2008)
  Annals of Oncology, 19 ​10th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

• 2008 | Conference Abstract
  ​ ​The RIT Network provides real life clinical data on radioimmunotherapy for lymphoma: An international registry for radioimmunotherapy-treated patients​
  Hohloch, K.; Lorsbach, M.; Zinzani, P. L.; Chairman, N. & Truemper, L. H.​ (2008)
  Annals of Oncology, 19 ​10th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

• 2008 | Journal Article | 
  ​ ​Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects​
  Kuehne, A.; Sezer, O.; Heider, U.; Meineke, I.; Muhlke, S.; Niere, W. & Overbeck, T. R. et al.​ (2008) 
  Clinical Pharmacology & Therapeutics, 83(5) pp. 749​-757​.​ DOI: https://doi.org/10.1038/sj.clpt.6100336 
  ​Details  DOI  PMID  PMC  WoS 

• 2009 | Journal Article
  ​ ​A Case of Bilateral Optic Disc Edema​
  Pfriem, M.; Overbeck, T. R.; Hohloch, K.; Tondrow, M. & Hoerauf, H.​ (2009) 
  Klinische Monatsblätter für Augenheilkunde, 226(2) pp. 130​-131​.​ DOI: https://doi.org/10.1055/s-2008-1027962 
  ​Details  DOI  PMID  PMC  WoS 

• 2009 | Journal Article
  ​ ​The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)​
  Buske, C.; Hoster, E.; Dreyling, M.; Eimermacher, H.; Wandt, H.; Metzner, B. & Fuchs, R. et al.​ (2009) 
  Leukemia, 23(1) pp. 153​-161​.​ DOI: https://doi.org/10.1038/leu.2008.261 
  ​Details  DOI  PMID  PMC  WoS 

• 2009 | Journal Article
  ​ ​Harnessing the Energy: Development of Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma​
  Gregory, S. A.; Hohloch, K.; Gisselbrecht, C.; Tobinai, K. & Dreyling, M. H.​ (2009) 
  The Oncologist, 14 pp. 4​-16​.​ DOI: https://doi.org/10.1634/theoncologist.2009-S2-4 
  ​Details  DOI  PMID  PMC  WoS 

• 2009 | Conference Paper
  ​ ​Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group​
  Stilgenbauer, S.; Zenz, T.; Winkler, D.; Buehler, A.; Schlenk, R. F.; Groner, S. & Busch, R. et al.​ (2009)
  Journal of Clinical Oncology, 27(24) pp. 3994​-4001. ​50th Annual Meeting of the American-Society-of-Hematology​, San Francisco, CA.
  Alexandria​: Amer Soc Clinical Oncology. DOI: https://doi.org/10.1200/JCO.2008.21.1128 
  ​Details  DOI  PMID  PMC  WoS 

• 2010 | Conference Abstract
  ​ ​Radioimmunotherapy for consolidation and relapse therapy for aggressive B-cell non-Hodgkin lymphoma: Retrospective analysis of the International RIT-Network.​
  Hohloch, K.; Windermuth-Kiesselbach, C.; Lorsbach, M.; Zinzani, P. L. & Truemper, L. H.​ (2010)
  Journal of Clinical Oncology, 28(15) 
  Alexandria​: Amer Soc Clinical Oncology.
  ​Details  WoS 

• 2011 | Conference Abstract
  ​ ​RADIOIMMUNOTHERAPY FOR CONSOLIDATION AND RELAPSE TREATMENT OF AGGRESSIVE B-CELL NON HODGKINS LYMPHOMA: AN UPDATED ANALYSIS OF THE INTERNATIONAL RIT-NETWORK​
  Hohloch, K.; Lankeit, H. K.; Zinzani, P. L.; Lorsbach, M.; Windemuth-Kiesselbach, C. & Truemper, L. H.​ (2011)
  Annals of Oncology, 22 ​11th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

• 2011 | Journal Article
  ​ ​Retrospective web-based multicenter evaluation of F-18-FDG-PET and CT derived predictive factors Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma​
  Grgic, A.; Nestle, U.; Scheidhauer, K.; Puskas, C.; Ballek, E.; Hohloch, K. & Schubert, J. et al.​ (2011) 
  Nuklearmedizin, 50(1) pp. 39​-47​.​
  ​Details  PMID  PMC  WoS 

• 2011 | Journal Article
  ​ ​Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect of ERCC1 polymorphisms​
  Tzvetkov, M. V.; Behrens, G.; O'Brien, V. P.; Hohloch, K.; Brockmoeller, J. & Benoehr, P. ​ (2011) 
  Pharmacogenomics, 12(10) pp. 1417​-1427​.​ DOI: https://doi.org/10.2217/PGS.11.93 
  ​Details  DOI  PMID  PMC  WoS 

• 2011 | Journal Article | 
  ​ ​Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with I-131-anti-CD20 antibody and stem cell rescue​
  Hohloch, K.; Sahlmann, C. O.; Lakhani, V. J.; Wulf, G.; Glass, B.; Hasenkamp, J. & Meller, J. et al.​ (2011) 
  Annals of Hematology, 90(11) pp. 1307​-1315​.​ DOI: https://doi.org/10.1007/s00277-011-1199-y 
  ​Details  DOI  PMID  PMC  WoS 

• 2011 | Journal Article | Letter Note
  ​ ​Radioimmunotherapy with Y-90-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network​
  Hohloch, K.; Zinzani, P. L.; Linkesch, W.; Jurczak, W.; Deptala, A.; Lorsbach, M. & Windemuth-Kiesselbach, C. et al.​ (2011) 
  Bone Marrow Transplantation, 46(6) pp. 901​-903​.​ DOI: https://doi.org/10.1038/bmt.2010.202 
  ​Details  DOI  PMID  PMC  WoS 

• 2011 | Journal Article
  ​ ​Radioimmunotherapy Confers Long-Term Survival to Lymphoma Patients with Acceptable Toxicity: Registry Analysis by the International Radioimmunotherapy Network​
  Hohloch, K.; Delaloye, A. B.; Windemuth-Kieselbach, C.; Gomez-Codina, J.; Linkesch, W.; Jurczak, W. & Cacchione, R. et al.​ (2011) 
  Journal of Nuclear Medicine, 52(9) pp. 1354​-1360​.​ DOI: https://doi.org/10.2967/jnumed.111.089920 
  ​Details  DOI  PMID  PMC  WoS 

• 2012 | Conference Abstract
  ​ ​Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))​
  Herfarth, K.; Engelhard, M.; Borchmann, P.; Hohloch, K.; Budach, V.; Viardot, A. & Witzens-Harig, M. et al.​ (2012)
  Blood, 120(21) , Atlanta, GA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2012 | Conference Abstract
  ​ ​Radioimmunotherapy efficiency and safety in consolidation and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: An updated analysis of 230 patients of the international RIT-network.​
  Hohloch, K.; Lankeit, H. K.; Zinzani, P. L.; Lorsbach, M.; Windemuth-Kiesselbach, C. & Truemper, L. H.​ (2012)
  Journal of Clinical Oncology, 30(15) ​48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)​, Chicago, IL.
  Alexandria​: Amer Soc Clinical Oncology.
  ​Details  WoS 

• 2013 | Journal Article | Letter Note
  ​ ​Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma​
  Schaefer, I.-M.; Marx, A.; Sauer, C.; Hohloch, K.; Ghadimi, B. M.; Truemper, L. H. & Stroebel, P.​ (2013) 
  Histopathology, 62(4) pp. 664​-667​.​ DOI: https://doi.org/10.1111/his.12051 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article
  ​ ​Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network​
  Hohloch, K.; Lankeit, H. K.; Zinzani, P. L.; Scholz, C. W.; Lorsbach, M.; Windemuth-Kieselbach, C. & Truemper, L. H.​ (2014) 
  European Journal of Nuclear Medicine and Molecular Imaging, 41(8) pp. 1585​-1592​.​ DOI: https://doi.org/10.1007/s00259-014-2758-y 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article | Letter Note
  ​ ​Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens​
  Hohloch, K.; Zeynalova, S.; Held, G.; Ziepert, M.; Loeffler, M.; Wulf, G. & Schmitz, N. et al.​ (2014) 
  Leukemia, 28(11) pp. 2260​-2263​.​ DOI: https://doi.org/10.1038/leu.2014.213 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article | 
  ​ ​Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL​
  Hohloch, K.; Zwick, C.; Ziepert, M.; Hasenclever, D.; Kaiser, U.; Engert, A. & Hoeffkes, H.-G. et al.​ (2014) 
  SpringerPlus, 3 art. 5​.​ DOI: https://doi.org/10.1186/2193-1801-3-5 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article
  ​ ​Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma​
  Meyer, A. H.; Stroux, A.; Lerch, K.; Eucker, J.; Eitle, J.; Hohloch, K. & Andrzejak, M. et al.​ (2014) 
  Annals of Oncology, 25(1) pp. 210​-215​.​ DOI: https://doi.org/10.1093/annonc/mdt507 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Aggressive B cell lymphomas in elderly patients. Curative or palliative treatment strategy?​
  Hohloch, K.; Zettl, F. & Truemper, L. H.​ (2015) 
  Der Onkologe, 21(6) pp. 496​-+​.​ DOI: https://doi.org/10.1007/s00761-014-2830-z 
  ​Details  DOI  WoS 

• 2015 | Conference Abstract
  ​ ​Obesity Is a Prognostic Factor in Elderly Female Patients with Aggressive B-Cell Lymphomas Treated with R-CHOP​
  Hohloch, K.; Altmann, B.; Pfreundschuh, M.; Loeffler, M.; Schmitz, N.; Ziepert, M. & Truemper, L. H.​ (2015)
  Blood, 126(23) ​57th Annual Meeting of the American-Society-of-Hematology​, Orlando, FL.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2016 | Journal Article | Research Paper
  ​ ​Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma​
  Hohloch, K.; Zeynalova, S.; Chapuy, B. ; Pfreundschuh, M.; Loeffler, M.; Ziepert, M. & Feller, A. C. et al.​ (2016) 
  Annals of Hematology, 95(7) pp. 1121​-1128​.​ DOI: https://doi.org/10.1007/s00277-016-2671-5 
  ​Details  DOI  PMID  PMC  WoS 

• 2017 | Journal Article
  ​ ​Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome​
  Fischer, A.; Bastian, S.; Cogliatti, S.; Mey, U.; Saub, J.; Schanz, U. & Padberg, B. et al.​ (2017) 
  Hematological Oncology, 36(1) pp. 370​-371​.​ DOI: https://doi.org/10.1002/hon.2464 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8-year follow-up data of 281 patients from the international RIT-registry​
  Hohloch, K.; Windemuth-Kieselbach, C.; Kolz, J.; Zinzani, P. L.; Cacchione, R.; Jurczak, W. & Bischof Delaloye, A. et al.​ (2018) 
  British Journal of Haematology, 184(6) pp. 949​-956​.​ DOI: https://doi.org/10.1111/bjh.15712 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma​
  Herfarth, K.; Borchmann, P.; Schnaidt, S.; Hohloch, K.; Budach, V.; Engelhard, M. & Viardot, A. et al.​ (2018) 
  HemaSphere, 2(6) pp. e160​.​ DOI: https://doi.org/10.1097/HS9.0000000000000160 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Radioimmunotherapy for Mantle Cell Lymphoma: 5-Year Follow-up of 90 Patients from the International RIT-Registry​
  Hohloch, K.; Windemuth-Kieselbach, C.; Zinzani, P. L.; Cacchione, R. E.; Jurczak, W.; Suh, C. & Truemper, L. et al.​ (2019) 
  Blood, 134(Supplement_1) pp. 5263​-5263​.​ DOI: https://doi.org/10.1182/blood-2019-124192 
  ​Details  DOI 

Researcher

Sort

Items per Page